Literature DB >> 24455552

Reply to: Metastasis to left scapula with unknown primary: Approach to pathological diagnosis.

Kanaram Choudhary1, Bhooraram Choudhary2, Akhil Nambyar3.   

Abstract

Entities:  

Year:  2013        PMID: 24455552      PMCID: PMC3876650          DOI: 10.4103/2278-330X.110486

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN: 2278-330X


× No keyword cloud information.
Sir, In a recent issue, an interesting case titled “Metastasis to left scapula with unknown primary: Approach to pathological diagnosis” was published by Shiasta et al.[1] In this case, the final diagnosis was given as metastatic adenocarcinoma, probably arising from the lungs. The majority of metastatic carcinomas of unknown primaries (MCUPs) in adults are adenocarcinomas and undifferentiated carcinomas, but the relative number of each differs depending on age and sex.[2] Huebner et al., in a case study of a series of 343 patients found that 40% of the metastatic tumors were adenocarcinoma, 28% were undifferentiated carcinoma, 14% were squamous cell carcinoma, and the remainder were poorly differentiated tumors.[3] Patients with visceral metastasis of carcinoma below the diaphragm had a poor prognosis and responded poorly to chemotherapy.[4] It is also important to identify carcinomas that can be treated by chemotherapy or hormonal manipulation or both, especially metastasis from breast and prostate.[5] For the final diagnosis, analysis of immunohistochemical (IHC) markers are of utmost importance. Therefore, treatment should be started from the lung and breast, depending on the gender.[5] To rule out lung adenocarcinoma, IHC panel of CK 7, CK 14, CK 20, and TTF-1 is very important. Because some mucinous adenocarcinomas are CK 20 positive, staining with mucicarmine may be fruitful. However, in the published case, CK 20 was negative. CK 20 positivity is extensively reported in colorectal cancer; in such a case, high resolution computed tomography can give better result than ultrasonography. In the published case, routine hematoxylin and eosin staining gave impression of paraganglionoma that has been ruled out by IHC. The expression of CK7 and CK20 is distinctive to glandular epithelia. This may include tumors like colorectal, pancreatic, or bronchoalveolar adenocarcinomas, as well as adenocarcinomas of the salivary glands.[6] TTF-1 is a nuclear tissue-specific protein transcription factor, found only in thyroid/thyroid tumors regardless of histological types, as well as in adenocarcinomas (75%), non-small cell carcinomas (63%), and small cell carcinomas (90%) of the lung.[78] Therefore, in the present case, TTF-1 staining would have given evidence in favor of lung adenocarcinoma. It has been noted in previous studies that no lung adenocarcinomas were CK20 positive, but almost all were CK7 positive, and 70% of the cases were TTF-1 positive.[9] Although salivary gland adenocarcinoma rarely metastasizes and is clinically evident, it should be included in differential diagnosis. Because rapid metastasis of salivary gland adenocarcinoma into the lung, brain, and multiple osseous site has been reported in literature.[1011] Here, staining with CK 7/14 and TTF-1 is useful. Salivary adenocarcinomas are positive for CK 7/14, negative for TTF-1, and negative for CK 20.[6] In conclusion, IHC markers with advanced radiological investigations are mainstay in the diagnosis of occult or unknown primaries.
  8 in total

1.  Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Authors:  D C Chhieng; J F Cangiarella; M F Zakowski; S Goswami; J M Cohen; H T Yee
Journal:  Cancer       Date:  2001-10-25       Impact factor: 6.860

2.  Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.

Authors:  S A Kambhu; D P Kelsen; J Fiore; D Niedzwiecki; D Chapman; V Vinciguerra; R Rosenbluth
Journal:  Am J Clin Oncol       Date:  1990-02       Impact factor: 2.339

3.  Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.

Authors:  C Di Loreto; V Di Lauro; F Puglisi; G Damante; D Fabbro; C A Beltrami
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

4.  Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung.

Authors:  M T Stahlman; M E Gray; J A Whitsett
Journal:  J Histochem Cytochem       Date:  1996-07       Impact factor: 2.479

5.  CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.

Authors:  S Meer; M Altini
Journal:  Histopathology       Date:  2007-07       Impact factor: 5.087

Review 6.  Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.

Authors:  J D Hainsworth; F A Greco
Journal:  Semin Oncol       Date:  1993-06       Impact factor: 4.929

7.  Metastasis to left scapula with unknown primary: Approach to pathological diagnosis.

Authors:  Shaista M Vasenwala; Hena A Ansari; Nazima Haider; Amir Bin Sabir; Aseeb Ur Rehman
Journal:  South Asian J Cancer       Date:  2013-01

8.  The buccal minor salivary glands as starting point for a metastasizing adenocarcinoma--report of a case.

Authors:  Tobias Ettl; Johannes Kleinheinz; Ravi Mehrotra; Stephan Schwarz; Torsten Eugen Reichert; Oliver Driemel
Journal:  Head Face Med       Date:  2008-07-30       Impact factor: 2.151

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.